112 related articles for article (PubMed ID: 30499772)
1. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features.
Olar A; Tran D; Mehta VP; Reinhardt A; Manekia JH; Garnovskaya M; Ellezam B; Luthra R; Sulman EP; Mohila CA; Campbell GA; Powell SZ; Fuller GN; Aldape KD; Adesina AM
Clin Neuropathol; 2019; 38(2):59-73. PubMed ID: 30499772
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
[TBL] [Abstract][Full Text] [Related]
3. Alternative lengthening of telomeres, ATRX loss and H3-K27M mutations in histologically defined pilocytic astrocytoma with anaplasia.
Rodriguez FJ; Brosnan-Cashman JA; Allen SJ; Vizcaino MA; Giannini C; Camelo-Piragua S; Webb M; Matsushita M; Wadhwani N; Tabbarah A; Hamideh D; Jiang L; Chen L; Arvanitis LD; Alnajar HH; Barber JR; Rodríguez-Velasco A; Orr B; Heaphy CM
Brain Pathol; 2019 Jan; 29(1):126-140. PubMed ID: 30192422
[TBL] [Abstract][Full Text] [Related]
4. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK
Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma.
Rodriguez EF; Scheithauer BW; Giannini C; Rynearson A; Cen L; Hoesley B; Gilmer-Flynn H; Sarkaria JN; Jenkins S; Long J; Rodriguez FJ
Acta Neuropathol; 2011 Mar; 121(3):407-20. PubMed ID: 21113787
[TBL] [Abstract][Full Text] [Related]
6. A case of high-grade astrocytoma with BRAF and ATRX mutations following a long-standing course over two decades.
Nakata S; Horiguchi K; Ishiuchi S; Yoshimoto Y; Yamada S; Nobusawa S; Ikota H; Hirato J; Yokoo H
Neuropathology; 2017 Aug; 37(4):351-357. PubMed ID: 28185325
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics of circumscribed high-grade astrocytomas with an unusual combination of BRAF V600E, ATRX, and CDKN2A/B alternations.
Murakami C; Yoshida Y; Yamazaki T; Yamazaki A; Nakata S; Hokama Y; Ishiuchi S; Akimoto J; Shishido-Hara Y; Yoshimoto Y; Matsumura N; Nobusawa S; Ikota H; Yokoo H
Brain Tumor Pathol; 2019 Jul; 36(3):103-111. PubMed ID: 30972500
[TBL] [Abstract][Full Text] [Related]
8. Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
Bucheit AD; Chen G; Siroy A; Tetzlaff M; Broaddus R; Milton D; Fox P; Bassett R; Hwu P; Gershenwald JE; Lazar AJ; Davies MA
Clin Cancer Res; 2014 Nov; 20(21):5527-36. PubMed ID: 25165098
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.
Wang AC; Jones DTW; Abecassis IJ; Cole BL; Leary SES; Lockwood CM; Chavez L; Capper D; Korshunov A; Fallah A; Wang S; Ene C; Olson JM; Geyer JR; Holland EC; Lee A; Ellenbogen RG; Ojemann JG
Mol Cancer Res; 2018 Oct; 16(10):1491-1498. PubMed ID: 30006355
[TBL] [Abstract][Full Text] [Related]
10. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
Halfpenny A; Ferris SP; Grafe M; Woltjer R; Selden N; Nazemi K; Perry A; Solomon DA; Gultekin SH; Moore S; Olson S; Lawce H; Lucas L; Corless CL; Wood MD
Neuropathology; 2019 Oct; 39(5):389-393. PubMed ID: 31435988
[TBL] [Abstract][Full Text] [Related]
11. The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population.
Gareton A; Tauziède-Espariat A; Dangouloff-Ros V; Roux A; Saffroy R; Castel D; Kergrohen T; Fina F; Figarella-Branger D; Pagès M; Bourdeaut F; Doz F; Puget S; Dufour C; Lechapt E; Chrétien F; Grill J; Varlet P
Acta Neuropathol; 2020 Feb; 139(2):287-303. PubMed ID: 31677015
[TBL] [Abstract][Full Text] [Related]
12. Acquired ATRX Loss and ALT Phenotype Through Tumor Recurrences in a Case of Pleomorphic Xanthoastrocytoma Suggest Their Possible Roles in Tumor Progression.
Dal Col P; Poncet D; Rivoirard R; Vassal F; Bernichon E; Boutet C; Péoc'h M; Forest F
J Neuropathol Exp Neurol; 2020 Sep; 79(9):1011-1014. PubMed ID: 32770176
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-driven diagnosis of diffuse gliomas.
Appin CL; Brat DJ
Mol Aspects Med; 2015 Nov; 45():87-96. PubMed ID: 26004297
[TBL] [Abstract][Full Text] [Related]
14. [Application of ATRX in diagnosis and prognostic evaluation of glioma].
Li Z; Piao YS; Zhang LY; Wang LM; Wang DD; Fu YJ; Cai YN; Lu DH
Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):690-694. PubMed ID: 29050070
[No Abstract] [Full Text] [Related]
15. Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss.
Yeo YH; Byrne NP; Counelis GJ; Perry A
Clin Neuropathol; 2013; 32(3):159-64. PubMed ID: 23196000
[TBL] [Abstract][Full Text] [Related]
16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of molecular biomarkers in gliomas.
Siegal T
J Clin Neurosci; 2015 Mar; 22(3):437-44. PubMed ID: 25533211
[TBL] [Abstract][Full Text] [Related]
18. ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.
Wiestler B; Capper D; Holland-Letz T; Korshunov A; von Deimling A; Pfister SM; Platten M; Weller M; Wick W
Acta Neuropathol; 2013 Sep; 126(3):443-51. PubMed ID: 23904111
[TBL] [Abstract][Full Text] [Related]
19. Combined "Infiltrating Astrocytoma/Pleomorphic Xanthoastrocytoma" Harboring IDH1 R132H and BRAF V600E Mutations.
Yamada S; Kipp BR; Voss JS; Giannini C; Raghunathan A
Am J Surg Pathol; 2016 Feb; 40(2):279-84. PubMed ID: 26414224
[TBL] [Abstract][Full Text] [Related]
20. Analysis of PIK3CA and B-RAF gene mutations in human astrocytomas: association with activation of ERK and AKT.
El-Habr EA; Tsiorva P; Theodorou M; Levidou G; Korkolopoulou P; Vretakos G; Petraki L; Michalopoulos NV; Patsouris E; Saetta AA
Clin Neuropathol; 2010; 29(4):239-45. PubMed ID: 20569675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]